Martijn Simons received the ‘Radboudumc Masterprijs Biomedical Sciences 2016-2017’ for his master internship entitled ‘The influence of a risk-based follow-up on the early detection of recurrences in patients treated for oropharyngeal cancer’.During his internship, Martijn explored possibilities to personalize the current follow-up schedule and reduce the number of follow-up consultations compared to the current consensus-based follow-up schedule. He was supervised by André Verbeek and Anne Aarts (theme Women's cancers) in collaboration with Robert Takes and Tim Govers (theme Rare cancers).
We would like to congratulate Martijn and his supervisors with this price. Martijn will continue his master’s piece of work as a PhD student at Maastricht University, focussing on the expected value of personalized care in cost-effectiveness analyses .
Related news items
Mireille Broeders appointed member of the Dutch Health Council16 November 2021
Mireille Broeders, professor of Personalized Cancer Screening, has been appointed as a member of the permanent Committee on Population Screening of the Dutch Health Council (Gezondheidsraad).read more
Optimizing workup in head and neck cancer (HNC)23 July 2020
In the journal Cancer RIHS researcher Henrieke Schutte described the outcomes after the implementation of a fast-track multidisciplinary integrated HNC care program: time-to-treatment was significantly reduced and survival and patient satisfaction increased significantly without increasing costs.read more
Mireille Broeders appointed full Professor of Personalized Cancer Screening18 June 2020
Mireille Broeders of the Department for Health Evidence has been appointed full professor of Personalized Cancer Screening. This appointment became effective on 1 May 2020.read more
Guiding the surgeon real-time tumor visualization during surgery26 February 2020
Incomplete excision of tumor tissue negatively affects the prognosis of the patient. RIHS researcher Mark Rijpkema and colleagues are working on the development of new dual-labeled tracers and currently are implementing this into the clinic.read more
Awarded KWF grants for Radboudumc researchers18 December 2019
KWF is investing 2.7 million euros in five different studies at Radboudumc. The awards are part of the new round of funding by DCS, in which over 34 million euros will be granted to Dutch cancer research. We congratulate our researchers with this funding and wish them success with their great work.read more